SCHEMBL8176997

SCHEMBL8176997

O=C1NC(=S)S/C1=C/c1ccc(Cc2ccccc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAT1 P18440 5/20 0.75
CA2 P00918 1/20 0.75
EPHX1 P07099 1/20 0.75
MMP13 P45452 3/20 0.70
MMP3 P08254 2/20 0.70
MYC P01106 3/20 0.70
MAX P61244 2/20 0.70
RAB9A P51151 2/20 0.70
NPC1 O15118 1/20 0.70
ADAMTS5 Q9UNA0 3/20 0.62
CISD1 Q9NZ45 1/20 0.62
IL1RN P18510 1/20 0.62
ERAP1 Q9NZ08 1/20 0.62
MEN1 O00255 1/20 0.60
PIM1 P11309 1/20 0.60
KMT2A Q03164 1/20 0.60
CTSD P07339 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8176998 1.00 NAT1 (0.75) NAT1CA2EPHX1MMP13MMP3
SCHEMBL3491175 0.86 NAT1 (1.00) NAT1CA2EPHX1MMP13MMP3
SCHEMBL4416451 0.86 NAT1 (1.00) NAT1CA2EPHX1MMP13MMP3
SCHEMBL1812224 0.86 NAT1 (1.00) NAT1CA2EPHX1MMP13MMP3
SCHEMBL1247509 0.84 NAT1 (1.00) NAT1CA2EPHX1MMP13MMP3
SCHEMBL1247510 0.84 NAT1 (1.00) NAT1CA2EPHX1MMP13MMP3
SCHEMBL10596480 0.84 NAT1 (1.00) NAT1CA2EPHX1MMP13MMP3
SCHEMBL12892045 0.83 MMP13 (1.00) NAT1CA2EPHX1MMP13MMP3
SCHEMBL1248973 0.83 MMP13 (1.00) NAT1CA2EPHX1MMP13MMP3
SCHEMBL4050544 0.83 MMP13 (0.91) NAT1CA2EPHX1MMP13MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018748-A1 RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 WO disclosed